185 related articles for article (PubMed ID: 33156523)
1. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
[TBL] [Abstract][Full Text] [Related]
2. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
4. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
Saussez S; Glinoer D; Chantrain G; Pattou F; Carnaille B; André S; Gabius HJ; Laurent G
Thyroid; 2008 Jul; 18(7):705-12. PubMed ID: 18630998
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis.
Lu Y; Li L
Technol Cancer Res Treat; 2021; 20():15330338211043784. PubMed ID: 34817271
[No Abstract] [Full Text] [Related]
6. Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases.
d'Alessandro M; De Vita E; Bergantini L; Mazzei MA; di Valvasone S; Bonizzoli M; Peris A; Sestini P; Bargagli E; Bennett D
Respir Physiol Neurobiol; 2020 Nov; 282():103546. PubMed ID: 32920057
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis.
Taliento C; Morciano G; Nero C; Froyman W; Vizzielli G; Pavone M; Salvioli S; Tormen M; Fiorica F; Scutiero G; Scambia G; Giorgi C; Greco P; Pinton P
Int J Gynecol Cancer; 2024 Jun; 34(6):906-918. PubMed ID: 38658022
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis.
Sun Q; Zhang Y; Liu M; Ye Z; Yu X; Xu X; Qin Y
Cancer Cell Int; 2019; 19():309. PubMed ID: 31832021
[TBL] [Abstract][Full Text] [Related]
9. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis.
Liu H; Dai Q; Li Y; Tang Z; She T
Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172
[TBL] [Abstract][Full Text] [Related]
10. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.
Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of galectins expression in patients with hepatic cancer: A meta-analysis.
Shao Q; He J; Chen Z; Wu C
Medicine (Baltimore); 2020 Apr; 99(15):e19622. PubMed ID: 32282710
[TBL] [Abstract][Full Text] [Related]
12. Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.
Labrie M; De Araujo LOF; Communal L; Mes-Masson AM; St-Pierre Y
Sci Rep; 2017 Oct; 7(1):13244. PubMed ID: 29038585
[TBL] [Abstract][Full Text] [Related]
13. Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications.
Mohamed RM; Emam A; Abdelfattah MM; Abdel-Mageed AI; Abdelhafeez MA; Helwa R
World J Surg Oncol; 2022 Sep; 20(1):276. PubMed ID: 36050693
[TBL] [Abstract][Full Text] [Related]
14. Serum galectin-1, galectin-3, and galectin-9 are bystander molecules for chronic spontaneous urticaria.
Zheng L; Shi ZR; Han YF; Luo YJ; Tang ZQ; Tan GZ; Wang L
Allergy; 2019 Oct; 74(10):1996-1998. PubMed ID: 31006131
[No Abstract] [Full Text] [Related]
15. Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke.
He XW; Li WL; Li C; Liu P; Shen YG; Zhu M; Jin XP
Sci Rep; 2017 Jan; 7():40994. PubMed ID: 28112232
[TBL] [Abstract][Full Text] [Related]
16. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
[TBL] [Abstract][Full Text] [Related]
17. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract][Full Text] [Related]
18. Serum galectins as potential biomarkers of inflammatory bowel diseases.
Yu TB; Dodd S; Yu LG; Subramanian S
PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.
Sideras K; de Man RA; Harrington SM; Polak WG; Zhou G; Schutz HM; Pedroza-Gonzalez A; Biermann K; Mancham S; Hansen BE; Bart Takkenberg R; van Vuuren AJ; Pan Q; Ijzermans JNM; Sleijfer S; Sprengers D; Dong H; Kwekkeboom J; Bruno MJ
Sci Rep; 2019 Jul; 9(1):10677. PubMed ID: 31337865
[TBL] [Abstract][Full Text] [Related]
20. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
